Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2011

01-06-2011 | Original Article

A comparison of antibiotic point prevalence survey data from four Irish regional/general hospitals

Authors: C. Naughton, Y. Hennessy, C. Mannion, M. Philbin

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2011

Login to get access

Abstract

Introduction

Point prevalence surveys (PPS) are increasingly used to examining and compare hospital antibiotic consumption. The aim of this study was to identify the (1) point prevalence of antibiotic use in one regional hospital and (2) compare PPS data from similar regional/general hospitals.

Methods

Data were collected on all inpatients with an active antibiotic prescription and on all prescriptions issued in the emergency department over a 24-h period. Point prevalence data were obtained from three other regional/general hospitals.

Results

The frequency of antibiotic use was hospital A = 29%, B = 38%, C = 34% and D = 37%. Overall, the most commonly prescribed antibiotic was co-amoxiclav (30%), followed by macrolides (12%). However, new generation broad-spectrum antibiotics, such as piperacillin/tazobactam or ciprofloxacin, were also commonly used. Prescribing for common conditions such as respiratory infection or cellulites showed diverse antibiotic selection.

Conclusion

Point prevalence survey data using a standardised methodology could facilitate both local audit and national benchmarking to monitor antibiotic use.
Literature
2.
go back to reference Goossens H (2005) European status of resistance in nosocomial infections. Chemotherapy 51(4):177–181PubMedCrossRef Goossens H (2005) European status of resistance in nosocomial infections. Chemotherapy 51(4):177–181PubMedCrossRef
3.
go back to reference Livermore D (2004) Can better prescribing turn the tide of resistance? Nat Rev Microbiol 2(1):73–78PubMedCrossRef Livermore D (2004) Can better prescribing turn the tide of resistance? Nat Rev Microbiol 2(1):73–78PubMedCrossRef
4.
go back to reference Mackenzie FM, Struelens MJ, Towner KJ, Gould IM (2005) Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC). Clin Microbiol Infect 11(11):938–954PubMedCrossRef Mackenzie FM, Struelens MJ, Towner KJ, Gould IM (2005) Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC). Clin Microbiol Infect 11(11):938–954PubMedCrossRef
8.
go back to reference Vlahovic-Palcevski V, Dumpis U, Mitt P et al (2007) Benchmarking antimicrobial drug use at university hospitals in five European countries. Clin Microbiol Infect 13(3):277–283PubMedCrossRef Vlahovic-Palcevski V, Dumpis U, Mitt P et al (2007) Benchmarking antimicrobial drug use at university hospitals in five European countries. Clin Microbiol Infect 13(3):277–283PubMedCrossRef
9.
go back to reference Bergman U, Popa C, Tomson Y et al (1998) Drug utilization 90%—a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 54(2):113–118PubMedCrossRef Bergman U, Popa C, Tomson Y et al (1998) Drug utilization 90%—a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 54(2):113–118PubMedCrossRef
10.
go back to reference Kern WV, de WK, Steib-Bauert M, Fellhauer M, Plangger A, Probst W (2005) Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001–2002. Infection 33(5–6):333–339PubMedCrossRef Kern WV, de WK, Steib-Bauert M, Fellhauer M, Plangger A, Probst W (2005) Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001–2002. Infection 33(5–6):333–339PubMedCrossRef
11.
go back to reference Ansari F, Erntell M, Goossens H, Davey P (2009) The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 49(10):1496–1504 Ansari F, Erntell M, Goossens H, Davey P (2009) The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 49(10):1496–1504
12.
go back to reference Kanerva M, Ollgren J, Lyytikainen O (2007) Antimicrobial use in Finnish acute care hospitals: data from national prevalence survey. J Antimicrob Chemother 60(2):440–444PubMedCrossRef Kanerva M, Ollgren J, Lyytikainen O (2007) Antimicrobial use in Finnish acute care hospitals: data from national prevalence survey. J Antimicrob Chemother 60(2):440–444PubMedCrossRef
13.
go back to reference McNulty CA, Francis NA (2009) Optimizing antibiotic prescribing in primary care settings in the UK: findings of a BSAC multi-disciplinary workshop. J Antimicrob Chemother 65(11):2278–2284CrossRef McNulty CA, Francis NA (2009) Optimizing antibiotic prescribing in primary care settings in the UK: findings of a BSAC multi-disciplinary workshop. J Antimicrob Chemother 65(11):2278–2284CrossRef
15.
go back to reference Naughton C, Feely J, Bennett K (2009) A RCT evaluating the effectiveness and cost-effectiveness of academic detailing versus postal prescribing feedback in changing GP antibiotic prescribing. J Eval Clin Pract 15(5):807–812PubMedCrossRef Naughton C, Feely J, Bennett K (2009) A RCT evaluating the effectiveness and cost-effectiveness of academic detailing versus postal prescribing feedback in changing GP antibiotic prescribing. J Eval Clin Pract 15(5):807–812PubMedCrossRef
Metadata
Title
A comparison of antibiotic point prevalence survey data from four Irish regional/general hospitals
Authors
C. Naughton
Y. Hennessy
C. Mannion
M. Philbin
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2011
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-011-0677-5

Other articles of this Issue 2/2011

Irish Journal of Medical Science (1971 -) 2/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.